Moderna requests authorization of COVID vaccine for kids ages 5 and under
![Woman with young child in stroller.](https://cdn.mos.cms.futurecdn.net/AaEhx9cVsBxnmfnXQdarqj-415-80.jpg)
Moderna on Thursday requested emergency use authorization of its COVID-19 vaccine for Americans ages 5 and under, a "highly anticipated step" toward protecting the last vulnerable age group in the U.S., The Washington Post reports.
The company's filing will likely push the U.S. Food and Drug Administration to move quickly, "as parents, pediatricians, and politicians have become increasingly impatient about the lack of vaccines and treatments to protect young children," the Post writes.
Moderna hopes a two-shot regimen will sufficiently protect the nation's youngest — though, as was the case with adults, such a regimen only proved modestly effective in preventing illness caused by the Omicron variant, notes both the Post and The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"There is an important unmet medical need here with these youngest kids," Moderna's Chief Medical Officer Dr. Paul Burton told AP. Two low-dose shots "will safely protect them. I think it is likely that over time they will need additional doses. But we're working on that."
Meanwhile, Pfizer is soon expected to announce whether its three-shot regimen effectively protects babies and toddlers, after having been directed to research adding another dose to its initial two.
FDA spokeswoman Stephnie Caccomo told the Post the agency would wait for Moderna's full filing — expected by the second week of May — and "review any [emergency use authorization] request it receives as quickly as possible using a science-based approach."
If/when the FDA clears vaccinations for the youngest age group, CDC recommendations come next.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Why the UK phone signal is so poor
Under The Radar Having trouble connecting? A lack of investment, planning rules and even your home could be to blame
By Elizabeth Carr-Ellis, The Week UK Published
-
Battleground states to watch in the 2024 election
In Depth These seven states could end up deciding who wins the White House this year
By Justin Klawans, The Week US Published
-
Leave the crowds behind at these 7 sensational hotels
The Week Recommends Traveling in September means more room to explore
By Catherine Garcia, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published